Close

PCDH7

All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.

PCDH7 belongs to the protocadherin gene family, a subfamily of the cadherin superfamily. The gene encodes a protein with an extracellular domain containing 7 cadherin repeats. The gene product is an integral membrane protein that is thought to function in cell-cell recognition and adhesion. Alternative splicing yields isoforms with unique cytoplasmic tails.
  • CAR Vector Products

Loading...
  • Target Species:
  • Antibody Clone:
  • Antibody Host:
  • Receptor Construction:
  • Vector Type:
  • Targeting Cell Type:
CAT Product Name Target Species Antibody Clone Antibody Host Receptor Construction Vector Type Targeting Cell Type CAR Vector Type Inquiry & Datasheet
CAR-0320ZP1617 Anti-PCDH7 (EML561) h(CD28-CD3ζ) CAR, pCDCAR1 Human EML561 Mouse scFv-CD28-CD3ζ Lentiviral vector T Cell   Add to Cart   Datasheet
CAR-0320ZP1618 Anti-PCDH7 (EML561) h(4-1BB-CD3ζ) CAR, pCDCAR1 Human EML561 Mouse scFv-4-1BB-CD3ζ Lentiviral vector T Cell   Add to Cart   Datasheet
CAR-0320ZP1619 Anti-PCDH7 (2D7) h(CD28-CD3ζ) CAR, pCDCAR1 Human 2D7 Mouse scFv-CD28-CD3ζ Lentiviral vector T Cell   Add to Cart   Datasheet
CAR-0320ZP1620 Anti-PCDH7 (2D7) h(4-1BB-CD3ζ) CAR, pCDCAR1 Human 2D7 Mouse scFv-4-1BB-CD3ζ Lentiviral vector T Cell   Add to Cart   Datasheet
CAR-0320ZP1621 Anti-PCDH7 (CBYC-P207) h(CD28-CD3ζ) CAR, pCDCAR1 Human CBYC-P207 Mouse scFv-CD28-CD3ζ Lentiviral vector T Cell   Add to Cart   Datasheet
CAR-0320ZP1622 Anti-PCDH7 (CBYC-P207) h(4-1BB-CD3ζ) CAR, pCDCAR1 Human CBYC-P207 Mouse scFv-4-1BB-CD3ζ Lentiviral vector T Cell   Add to Cart   Datasheet
CAR-0320ZP1623 Anti-PCDH7 (CBYC-P206) h(CD28-CD3ζ) CAR, pCDCAR1 Human CBYC-P206 Mouse scFv-CD28-CD3ζ Lentiviral vector T Cell   Add to Cart   Datasheet
CAR-0320ZP1624 Anti-PCDH7 (CBYC-P206) h(4-1BB-CD3ζ) CAR, pCDCAR1 Human CBYC-P206 Mouse scFv-4-1BB-CD3ζ Lentiviral vector T Cell   Add to Cart   Datasheet
CAR-0320ZP1625 Anti-PCDH7 (2G6) h(CD28-CD3ζ) CAR, pCDCAR1 Human 2G6 Mouse scFv-CD28-CD3ζ Lentiviral vector T Cell   Add to Cart   Datasheet
CAR-0320ZP1626 Anti-PCDH7 (2G6) h(4-1BB-CD3ζ) CAR, pCDCAR1 Human 2G6 Mouse scFv-4-1BB-CD3ζ Lentiviral vector T Cell   Add to Cart   Datasheet
CAR-0320ZP1627 Anti-PCDH7 (1F9) h(CD28-CD3ζ) CAR, pCDCAR1 Human 1F9 Mouse scFv-CD28-CD3ζ Lentiviral vector T Cell   Add to Cart   Datasheet
CAR-0320ZP1628 Anti-PCDH7 (1F9) h(4-1BB-CD3ζ) CAR, pCDCAR1 Human 1F9 Mouse scFv-4-1BB-CD3ζ Lentiviral vector T Cell   Add to Cart   Datasheet
CAR-0320ZP1629 Anti-PCDH7 (1F7) h(CD28-CD3ζ) CAR, pCDCAR1 Human 1F7 Mouse scFv-CD28-CD3ζ Lentiviral vector T Cell   Add to Cart   Datasheet
CAR-0320ZP1630 Anti-PCDH7 (1F7) h(4-1BB-CD3ζ) CAR, pCDCAR1 Human 1F7 Mouse scFv-4-1BB-CD3ζ Lentiviral vector T Cell   Add to Cart   Datasheet
CAR-0320ZP1631 Anti-PCDH7 (1A2) h(CD28-CD3ζ) CAR, pCDCAR1 Human 1A2 Mouse scFv-CD28-CD3ζ Lentiviral vector T Cell   Add to Cart   Datasheet
CAR-0320ZP1632 Anti-PCDH7 (1A2) h(4-1BB-CD3ζ) CAR, pCDCAR1 Human 1A2 Mouse scFv-4-1BB-CD3ζ Lentiviral vector T Cell   Add to Cart   Datasheet
Unable to find the desired product? Explore the Filter Options at the top of the list.
Key Updates
Newsletter NEWSLETTER

The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders

LEARN MORE NEWSLETTER
New Solution NEW SOLUTION

CellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.

LEARN MORE SOLUTION
NOVEL SOLUTION NOVEL TECHNOLOGY

Silence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.

LEARN MORE NOVEL TECHNOLOGY
NEW TECHNOLOGY NEW SOLUTION

Canine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.

LEARN MORE SOLUTION
Receive our latest news and insights.